A

Agios Pharmaceuticals
D

AGIO

29.850
USD
0.26
(0.88%)
مغلق
حجم التداول
15,560
الربح لكل سهم
-7
العائد الربحي
-
P/E
3
حجم السوق
1,728,768,690
أصول ذات صلة
B
BLUE
0.00500
(0.10%)
4.99000 USD
BMRN
BMRN
-0.490
(-0.85%)
57.500 USD
C
CRSP
-0.760
(-2.02%)
36.850 USD
E
EDIT
-0.07000
(-4.32%)
1.55000 USD
E
EXEL
-0.480
(-1.12%)
42.380 USD
GILD
GILD
0.670
(0.63%)
107.390 USD
N
NKTR
0.00400
(0.62%)
0.64810 USD
S
SRPT
-0.900
(-2.32%)
37.900 USD
المزيد
الأخبار المقالات

العنوان: Agios Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.